However, several reports have shown that BRCA1 expression loss in Her2-positive sporadic breast tumors is associated with worse prognostic features (e.g., higher histological grade, increased proliferation), early progression [38], and a poor survival rate [39,40]. This evidence concerns the gene ERBB2 and breast neoplasm.